Cart
sales@molnova.com
5-O-Caffeoylshikimic acid
CAS No. 73263-62-4
5-O-Caffeoylshikimic acid( —— )
Catalog No. M24740 CAS No. 73263-62-4
5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 255 | In Stock |
|
| 5MG | 246 | In Stock |
|
| 10MG | 367 | In Stock |
|
| 25MG | 603 | In Stock |
|
| 50MG | 830 | In Stock |
|
| 100MG | 1097 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product Name5-O-Caffeoylshikimic acid
-
NoteResearch use only, not for human use.
-
Brief Description5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.
-
Description5-O-Caffeoylshikimic acid shows anti-oxidative activity; it also shows anti-inflammatory activity, the underlying mechanism was associated with downregulation of nuclear factor-κB.
-
In Vitro5-O-cafeoylshikimic acid likely to be a key player to modulate NSCLC drug resistance in the near future.
-
In Vivo——
-
Synonyms——
-
PathwayApoptosis
-
TargetIL Receptor
-
RecptorIL Receptor|NO Synthase|TNF-α
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number73263-62-4
-
Formula Weight336.29
-
Molecular FormulaC16H16O8
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 100 mg/mL (297.36 mM)
-
SMILESO[C@@H]([C@@H](CC(C(O)=O)=C1)OC(/C=C/c(cc2)cc(O)c2O)=O)[C@@H]1O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Screening of some saponins and phenolic components of Tribulus terrestris and Smilax excelsa as MDR modulators.In Vivo. 2009 Jul-Aug;23(4):545-50.
molnova catalog
related products
-
YM-90709
A potent IL-5 receptor antagonist that inhibits the binding of IL-5 to its receptor on peripheral human eosinophils and butyric acid-treated eosinophilic HL-60 clone 15 cells with IC50 of 1.0 and 0.57 uM, respectively.
-
Reslizumab
Reslizumab (Sch 55700) is a humanized immunoglobulin G (IgG)4 κ monoclonal antibody that binds to human interleukin 5, thereby decreasing eosinophil production and survival.
-
Angoline
Angoline hydrochloride is a potent and selective IL6/STAT3 signaling pathway inhibitor(IC50 : 11.56 μM).
